Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism

We examined the in vivo effects of the hallucinogen 4-iodo-2,5-dimethoxyamphetamine (DOI). DOI suppressed the firing rate of 7 of 12 dorsal raphe (DR) serotonergic (5-HT) neurons and partially inhibited the rest (ED50 = 20 μg/kg, i.v.), an effect reversed by M100907 (5-HT2A antagonist) and picrotoxinin (GABAA antagonist). DOI (1 mg/kg, s.c.) reduced the 5-HT release in medial prefrontal cortex (mPFC) to 33 ± 8% of baseline, an effect also antagonized by M100907. However, the local application of DOI in the mPFC increased 5-HT release (164 ± 6% at 100 μm), an effect antagonized by tetrodotoxin, M100907, and BAY × 3702 (5-HT1A agonist) but not by SB 242084 (5-HT2C antagonist). The 5-HT increase was also reversed by NBQX (AMPA–KA antagonist) and 1S,3S-ACPD (mGluR 2/3 agonist) but not by MK-801 (NMDA antagonist). AMPA mimicked the 5-HT elevation produced by DOI. Likewise, the electrical–chemical stimulation of thalamocortical afferents and the local inhibition of glutamate uptake increased the 5-HT release through AMPA receptors. DOI application in mPFC increased the firing rate of a subgroup of 5-HT neurons (5 of 10), indicating an enhanced output of pyramidal neurons. Dual-label fluorescence confocal microscopic studies demonstrated colocalization of 5-HT1Aand 5-HT2A receptors on individual cortical pyramidal neurons. Thus, DOI reduces the activity of ascending 5-HT neurons through a DR-based action and enhances serotonergic and glutamatergic transmission in mPFC through 5-HT2A and AMPA receptors. Because pyramidal neurons coexpress 5-HT1A and 5-HT2A receptors, DOI disrupts the balance between excitatory and inhibitory inputs and leads to an increased activity that may mediate its hallucinogenic action.

[1]  Rex Y. Wang,et al.  Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition , 1977, Brain Research.

[2]  G. Aghajanian,et al.  Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique , 1977, Brain Research.

[3]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[4]  J. Fuster.  Prefrontal Cortex , 2018 .

[5]  H. Spinnler.  The prefrontal cortex, Anatomy, physiology, and neuropsychology of the frontal lobe, J.M. Fuster. Raven Press, New York (1980), IX-222 pages , 1981 .

[6]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[7]  L. Swanson.  The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[8]  J. Tepper,et al.  Antidromic activation of dorsal raphe neurons from neostriatum: Physiological characterization and effects of terminal autoreceptor activation , 1985, Brain Research.

[9]  R. Roth,et al.  Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin , 1989, The Journal of comparative neurology.

[10]  G. Chiara,et al.  Serotonin release estimated by transcortical dialysis in freely-moving rats , 1989, Neuroscience.

[11]  C. Marsden,et al.  Effects of a selective 5‐HT2 agonist, DOI, on 5‐HT neuronal firing in the dorsal raphe nucleus and 5‐HT release and metabolism in the frontal cortex , 1990, British journal of pharmacology.

[12]  R. Andrade,et al.  5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex , 1991, Neuroscience.

[13]  E. Kidd,et al.  Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI. , 1991, European journal of pharmacology.

[14]  M. Pompeiano,et al.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  L. Fowler,et al.  Tonic desensitization of hippocampal α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors regulates 5-hydroxytryptamine release in vivo , 1994, Neuroscience.

[16]  K. Ohta,et al.  Presynaptic glutamate receptors facilitate release of norepinephrine and 5-hydroxytryptamine as well as dopamine in the normal and ischemic striatum. , 1994, Journal of the autonomic nervous system.

[17]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[18]  J. Tepper,et al.  Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons , 1996, Brain Research.

[19]  Mustapha Riad,et al.  Immunocytochemical localization of serotonin1A receptors in the rat central nervous system , 1996, The Journal of comparative neurology.

[20]  B. Roth,et al.  Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. , 1996, Molecular pharmacology.

[21]  P. Goldman-Rakic,et al.  Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy , 1996, The Journal of comparative neurology.

[22]  B. Westerink,et al.  Brain microdialysis of GABA and glutamate: What does it signify? , 1997, Synapse.

[23]  A. Deutch,et al.  Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex , 1997, Synapse.

[24]  R Tao,et al.  Influence of AMPA/kainate receptors on extracellular 5‐hydroxytryptamine in rat midbrain raphe and forebrain , 1997, British journal of pharmacology.

[25]  F. Rossi,et al.  AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo , 1997, Neurochemistry International.

[26]  G. Aghajanian,et al.  Serotonin Induces Excitatory Postsynaptic Potentials in Apical Dendrites of Neocortical Pyramidal Cells , 1997, Neuropharmacology.

[27]  C. Rampon,et al.  Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods , 1997, Neuroscience.

[28]  M. Hajós,et al.  An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat , 1998, Neuroscience.

[29]  P S Goldman-Rakic,et al.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Aghajanian,et al.  5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by μ-opiate receptor activation , 1998, Neuroscience.

[31]  W. Kroeze,et al.  The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis , 1998, Biological Psychiatry.

[32]  J. Greuel,et al.  Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. , 1998, The Journal of pharmacology and experimental therapeutics.

[33]  L. JakabR,et al.  霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位 , 1998 .

[34]  F. Artigas,et al.  A microdialysis study of the in vivo release of 5‐HT in the median raphe nucleus of the rat , 1998, British journal of pharmacology.

[35]  H. Meltzer.  The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.

[36]  G. Aghajanian,et al.  Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release , 1999, Brain Research.

[37]  F. Artigas,et al.  Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. , 1999, Neuroreport.

[38]  B. Roth,et al.  Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo , 1999, Neuroscience.

[39]  M. Millan,et al.  Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats , 1999, Neuropharmacology.

[40]  G. Aghajanian,et al.  Serotonin–Glutamate Interactions: A New Target for Antipsychotic Drugs , 1999, Neuropsychopharmacology.

[41]  R. Roth,et al.  5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex , 1999, Neuropsychopharmacology.

[42]  C. Montigny,et al.  Modulation of the firing activity of rat serotonin and noradrenaline neurons by (±)pindolol , 1999, Biological Psychiatry.

[43]  K. Perry,et al.  Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum , 2000, Brain Research.

[44]  P. Lestage,et al.  (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices. , 2000, European journal of pharmacology.

[45]  G. Aghajanian,et al.  Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus , 2000, Brain Research.

[46]  P. Celada,et al.  In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[47]  G. Aghajanian,et al.  Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. , 2000, The Journal of pharmacology and experimental therapeutics.

[48]  G. Aghajanian,et al.  Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. , 2000, Brain research.

[49]  G. Aghajanian,et al.  Serotonin model of schizophrenia: emerging role of glutamate mechanisms , 2000, Brain Research Reviews.

[50]  L. Kubin,et al.  Pontomedullary distribution of 5‐HT2A receptor‐like protein in the rat , 2000, The Journal of comparative neurology.

[51]  F. Artigas,et al.  Local modulation of the 5-HT release in the dorsal striatum of the rat: an in vivo microdialysis study , 2000, European Neuropsychopharmacology.

[52]  A. Deutch,et al.  DOI-Induced Activation of the Cortex: Dependence on 5-HT2A Heteroceptors on Thalamocortical Glutamatergic Neurons , 2000, The Journal of Neuroscience.

[53]  P. Goldman-Rakic,et al.  Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. , 2000, Cerebral cortex.

[54]  T. Blackburn,et al.  Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS , 2000, Neuropharmacology.

[55]  S. Pandey,et al.  Cellular localization of serotonin2A (5HT2A) receptors in the rat brain , 2000, Brain Research Bulletin.

[56]  T. Robbins,et al.  Chemical neuromodulation of frontal-executive functions in humans and other animals , 2000, Experimental Brain Research.

[57]  S. Pandey,et al.  Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. , 2000, Brain research bulletin.

[58]  P. Goldman-Rakic,et al.  Segregation of serotonin 5‐HT2A and 5‐HT3 receptors in inhibitory circuits of the primate cerebral cortex , 2000, The Journal of comparative neurology.

[59]  K. Perry,et al.  Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade , 2001, Neuropharmacology.

[60]  J. Gewirtz,et al.  A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex , 2001, Neuroscience.

[61]  H. Meltzer,et al.  5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release , 2001, Journal of neurochemistry.

[62]  P. Celada,et al.  Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors , 2001, The Journal of Neuroscience.